June 7, 2017
Amniotic-derived Product False Claim

Another Amniotic-derived Product Mis-states FDA Compliance

During a course offered by ASIPP last March in Las Vegas, NV, I gave a brief impromptu presentation about regulatory issues in the field of translational regenerative medicine. I mentioned that producers of placental tissue-derived products, like amniotic fluid products or amniotic fluid plus micronized amniotic tissue products, were sprouting like weeds, despite the issuing...
Read More